Literature DB >> 26858085

Enhancement of Proliferation and Invasion of Gastric Cancer Cell by KDM5C Via Decrease in p53 Expression.

Liming Xu1, Wei Wu1, Guilian Cheng1, Mingjie Qian1, Kewei Hu1, Guojian Yin1, Shaofeng Wang1.   

Abstract

Gastric cancer is a malignancy with high incidence and the second leading cause of cancer death worldwide. Development of efficient therapies against gastric cancer is urgent. Until now, the mechanisms of gastric cancer genesis remain elusive. The KDM5C is a histone demethylase that promotes cancer cell growth and is enriched in drug-resistant cancer cells. But the pathogenic breadth and mechanistic aspects of this effect relative to gastric cancer have not been defined. In present study, we found that KDM5C was overexpressed in gastric cancer cell lines and gastric cancer tissues but not in normal gastric tissues. The proliferation and invasive potential of gastric cancer cells was significantly increased by ectopic expression of KDM5C. Contrarily, RNA interference targeting KDM5C in gastric cancer cells significantly decreased the proliferation and invasive potential of cells. Moreover, we also found that the expression of p53 was modulated by KDM5C. Cells with overexpression of KDM5C exhibited greatly decreased p53 expression, whereas silencing of KDM5C expression dramatically increased p53 expression at both the messenger RNA and protein levels. Inhibition of p53 by small-interfering RNA reversed the shKDM5C-induced proliferation and invasion. Our results collectively suggested that KDM5C played a role in gastric cancer cells proliferation and invasion, which may be partly associated with the p53 expression.

Entities:  

Keywords:  KDM5C; gastric cancer; invasion; p53; proliferation

Mesh:

Substances:

Year:  2016        PMID: 26858085      PMCID: PMC5616025          DOI: 10.1177/1533034616629261

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  26 in total

1.  The histone demethylase JMJD2B plays an essential role in human carcinogenesis through positive regulation of cyclin-dependent kinase 6.

Authors:  Gouji Toyokawa; Hyun-Soo Cho; Yukiko Iwai; Masanori Yoshimatsu; Masashi Takawa; Shinya Hayami; Kazuhiro Maejima; Noriaki Shimizu; Hirotoshi Tanaka; Tatsuhiko Tsunoda; Helen I Field; John D Kelly; David E Neal; Bruce A J Ponder; Yoshihiko Maehara; Yusuke Nakamura; Ryuji Hamamoto
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-19

2.  Lung cancer patients with an abnormal gene benefit from targeted therapy.

Authors:  Carrie Printz
Journal:  Cancer       Date:  2013-10-15       Impact factor: 6.860

3.  The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth.

Authors:  Jun Yang; Adrian M Jubb; Luke Pike; Francesca M Buffa; Helen Turley; Dilair Baban; Russell Leek; Kevin C Gatter; Jiannis Ragoussis; Adrian L Harris
Journal:  Cancer Res       Date:  2010-08-03       Impact factor: 12.701

4.  Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases.

Authors:  Johnathan R Whetstine; Amanda Nottke; Fei Lan; Maite Huarte; Sarit Smolikov; Zhongzhou Chen; Eric Spooner; En Li; Gongyi Zhang; Monica Colaiacovo; Yang Shi
Journal:  Cell       Date:  2006-04-06       Impact factor: 41.582

Review 5.  Recent advances in non-small cell lung cancer biology and clinical management.

Authors:  Pierre Saintigny; Jan A Burger
Journal:  Discov Med       Date:  2012-04       Impact factor: 2.970

Review 6.  The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression.

Authors:  Leah C Young; Michael J Hendzel
Journal:  Biochem Cell Biol       Date:  2012-12-05       Impact factor: 3.626

7.  Transient JMJD2B-mediated reduction of H3K9me3 levels improves reprogramming of embryonic stem cells into cloned embryos.

Authors:  Jisha Antony; Fleur Oback; Larry W Chamley; Björn Oback; Götz Laible
Journal:  Mol Cell Biol       Date:  2012-12-21       Impact factor: 4.272

Review 8.  P53 mutations in triple negative breast cancer upregulate endosomal recycling of epidermal growth factor receptor (EGFR) increasing its oncogenic potency.

Authors:  Iuliana Shapira; Annette Lee; Reena Vora; Daniel R Budman
Journal:  Crit Rev Oncol Hematol       Date:  2013-06-05       Impact factor: 6.312

9.  The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover.

Authors:  Kelly Coffey; Lynsey Rogerson; Claudia Ryan-Munden; Dhuha Alkharaif; Jacqueline Stockley; Rakesh Heer; Kanagasabai Sahadevan; Daniel O'Neill; Dominic Jones; Steven Darby; Peter Staller; Alejandra Mantilla; Luke Gaughan; Craig N Robson
Journal:  Nucleic Acids Res       Date:  2013-02-21       Impact factor: 16.971

10.  Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer.

Authors:  L Chen; L Fu; X Kong; J Xu; Z Wang; X Ma; Y Akiyama; Y Chen; J Fang
Journal:  Br J Cancer       Date:  2014-01-28       Impact factor: 7.640

View more
  16 in total

1.  Histone demethylase PHF8 promotes progression and metastasis of gastric cancer.

Authors:  Shuyan Li; Ao Sun; Xiuming Liang; Lin Ma; Li Shen; Tongyu Li; Lixin Zheng; Wenjing Shang; Wei Zhao; Jihui Jia
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  ELK1 activated-long noncoding RNA LBX2-AS1 aggravates the progression of ovarian cancer through targeting miR-4784/KDM5C axis.

Authors:  Hangzhi Gu; Rongrong Lin; Feiyun Zheng; Qian Zhang
Journal:  J Mol Histol       Date:  2020-10-24       Impact factor: 2.611

3.  Xist RNA repeat E is essential for ASH2L recruitment to the inactive X and regulates histone modifications and escape gene expression.

Authors:  Minghui Yue; Akiyo Ogawa; Norishige Yamada; John Lalith Charles Richard; Artem Barski; Yuya Ogawa
Journal:  PLoS Genet       Date:  2017-07-07       Impact factor: 5.917

4.  Characterization of brain tumor initiating cells isolated from an animal model of CNS primitive neuroectodermal tumors.

Authors:  Sergey Malchenko; Simone T Sredni; Jerusha Boyineni; Yingtao Bi; Naira V Margaryan; Maheedhara R Guda; Yulia Kostenko; Tadanori Tomita; Ramana V Davuluri; Kiran Velpula; Mary J C Hendrix; Marcelo B Soares
Journal:  Oncotarget       Date:  2018-02-09

5.  Genetic polymorphisms and gastric cancer risk: a comprehensive review synopsis from meta-analysis and genome-wide association studies.

Authors:  Jie Tian; Guanchu Liu; Chunjian Zuo; Caiyang Liu; Wanlun He; Huanwen Chen
Journal:  Cancer Biol Med       Date:  2019-05       Impact factor: 5.347

6.  KDM5C Expedites Lung Cancer Growth and Metastasis Through Epigenetic Regulation of MicroRNA-133a.

Authors:  Quan Zhang; Lei Xu; Jianjun Wang; Xiaoming Zhu; Zeheng Ma; Junfeng Yang; Jiwei Li; Xiangbo Jia; Li Wei
Journal:  Onco Targets Ther       Date:  2021-02-22       Impact factor: 4.147

7.  Mitochondrial pathway of the lysine demethylase 5C inhibitor CPI-455 in the Eca-109 esophageal squamous cell carcinoma cell line.

Authors:  Xiao-Jie Xue; Fei-Rong Li; Jing Yu
Journal:  World J Gastroenterol       Date:  2021-04-28       Impact factor: 5.742

Review 8.  Computational methods for cancer driver discovery: A survey.

Authors:  Vu Viet Hoang Pham; Lin Liu; Cameron Bracken; Gregory Goodall; Jiuyong Li; Thuc Duy Le
Journal:  Theranostics       Date:  2021-03-20       Impact factor: 11.556

9.  Lysine (K)-specific demethylase 5C regulates the incidence of severe preeclampsia by adjusting the expression of bone morphogenetic protein-7.

Authors:  Xu-Feng Shi; Zhan Zhang; Hai-Ying Wu; Yu Wang; Ai-Min Chang; Jun-Jun Gao; Kan Liu; Wan-Yu Song; Li Wang; Huan-Ping Wang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

10.  Association of Vascular Endothelial Growth Factor ( VEGF) Gene Polymorphisms With Gastric Cancer and Its Development, Prognosis, and Survival.

Authors:  Weimin Liu; Zhiyong Dong; Ruixiang Hu; Cunchuan Wang
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.